Martin Floreani

Martin Floreani is a seasoned executive with extensive experience in commercial leadership and strategic management across various industries, including healthcare and consumer goods. Currently serving as Chief Commercial Officer at Newmedical Technology, Inc., Martin oversees the global success of prominent brands in scar and bruise management. Previous roles include Senior Executive Consultant at Bayshore Dental Studio, where responsibilities encompassed marketing and business development, and CEO of Dentovations Inc., responsible for launching multiple brands during the pandemic. Martin has also held significant positions at French Transit, LLC, Enaltus, Advanced Bio-Technologies, and Stiefel Laboratories, demonstrating a strong track record in P&L management, strategic planning, and market development. An MBA graduate from the University of Miami, Martin possesses in-depth expertise in finance and marketing, further solidified by valuable roles at Merck and Kao Corporation.